Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who experienced the last acute mood episode during the last 2 months and are in euthymic state (YMRS score ≤12 and HAM-D score ≤12) for at least two weeks
Diagnosis of bipolar disorder I or II (as per DSM-IV), with or without rapid cycling
Subjects who have been treated with at least one atypical antipsychotic for the management of an acute mood event (manic or depressive) as monotherapy or in combination with other medication
Provision of informed consent prior to study participation
You may not be if
Subjects fulfilling criteria for diagnosis of any other psychiatric condition (except from bipolar disorder I or II), as per DSM-IV Axis Ι, concomitant organic mental disorder or mental retardation
Subjects who have received treatment with a depot
Substance abuse or dependence (with the exception of nicotine dependence), as defined by DSM-IV criteria
Inability of subjects to comply with the study protocol.
